The Hybrid Pyrroloisoindolone-Dehydropyrrolizine Alkaloid (-)-Chlorizidine A Targets Proteins within the Glycolytic Pathway

Xavier Álvarez-Micõ, Danilo D. Rocha, Larissa A. Guimarães, Andrew Ambrose, Eli Chapman, Leticia V. Costa-Lotufo, James J. La Clair, William Fenical

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Abstract

The cytotoxic activity of (-)-chlorizidine A, a marine alkaloid containing a unique fusion between a pyrroloisoindolone and dehydropyrrolizine, was explored by using a combination of cellular and molecular methods. Our studies began by applying preliminary SAR evidence gathered from semisynthetic bioactivity evaluations to prepare an active immunoaffinity fluorescent (IAF) probe. This probe was then used to identify two cytosolic proteins, GAPDH and hENO1, as the targets of (-)-chlorizidine A. Cellular and molecular biological studies have identified that the chlorinated marine alkaloid (-)-chlorizidine A targets the cytosolic proteins GAPDH and ENO1, two multifunctional proteins associated with the glycolytic pathway and implicated in multiple diseases, including metastatic cancer, autoimmune disorders, neurological disorders, and bacterial infections.

Original languageEnglish (US)
Pages (from-to)2002-2006
Number of pages5
JournalChemBioChem
Volume16
Issue number14
DOIs
StatePublished - Sep 1 2015

Keywords

  • drug discovery
  • enolase
  • glycolysis
  • mode of action
  • natural products

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Organic Chemistry

Fingerprint Dive into the research topics of 'The Hybrid Pyrroloisoindolone-Dehydropyrrolizine Alkaloid (-)-Chlorizidine A Targets Proteins within the Glycolytic Pathway'. Together they form a unique fingerprint.

Cite this